Free Trial
NASDAQ:SURG

SurgePays (SURG) Stock Price, News & Analysis

$3.00
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$2.96
$3.04
50-Day Range
$2.80
$4.28
52-Week Range
$2.75
$9.23
Volume
91,273 shs
Average Volume
500,157 shs
Market Capitalization
$58.23 million
P/E Ratio
2.61
Dividend Yield
N/A
Price Target
$9.50

SurgePays MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
216.7% Upside
$9.50 Price Target
Short Interest
Healthy
3.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of SurgePays in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$186,158 Sold Last Quarter
Proj. Earnings Growth
1,933.33%
From $0.03 to $0.61 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.39 out of 5 stars

Computer And Technology Sector

127th out of 612 stocks

Telephone Communication, Except Radio Industry

5th out of 19 stocks

SURG stock logo

About SurgePays Stock (NASDAQ:SURG)

Surgepays Inc is a technology and financial services company specializing in providing distribution, logistics, and digital marketing services to convenience stores, bodegas, and other small retailers. The company was founded in 2016 and is headquartered in Bartlett, Tennessee. Surgepays is focused on helping small businesses compete against larger retailers by assisting them to provide telecommunications and fintech products and services. The company operates in a highly competitive industry and has been able to differentiate itself by leveraging its technology and logistics expertise.

The leadership team at Surgepays Inc comprises experienced professionals with backgrounds in technology, finance, and logistics. The company's CEO is Brian Cox, who has over 15 years of experience in the technology industry, including serving as the CTO of a publicly-traded company. The CFO is Anthony Evers, who has over 15 years of experience in finance and accounting, including working for a Big Four accounting firm. The President of Surgepays Fintech, Jeremy Gies, previously worked as their Senior Channel Business Manager at Honeywell Voice Solutions. Jeremy Gies has a long history of working in telecom sales and development. 

Surgepays Inc has experienced consistent revenue growth over the past few years but has also missed the mark on expected earnings per share (EPS) nearly every quarter for the past few years. The company has been working on increasing its gross profit margin and has made some upward movement regarding that. Surgepays has achieved this growth through a combination of organic growth and strategic acquisitions. The company recently reached a subscriber goal by passing over 200,000 subscribers in Q4 of 2022. However, the company is in debt, with a debt-to-equity ratio significantly higher than industry averages. The company has also recently completed a 1 for 50 reverse stock split, which has helped to reduce its outstanding shares and improve its financial position. Surgepays Inc's price-to-earnings ratio is significantly lower than the industry average, and the company's price-to-book ratio is also relatively low. These valuation metrics suggest that Surgepays may be undervalued relative to its peers. Surgepays Inc has had a volatile stock performance over the past year. The company has also experienced an increase in trading volume over the past year, with an average daily trading volume of around 100,000 shares daily.

Surgepays Inc operates in the highly competitive convenience store and bodega distribution industry, dominated by large retailers such as Walmart and Amazon. However, the company has been able to differentiate itself by focusing on small retailers and underserved customers in the fintech space. The industry also faces increasing regulatory and political pressures, primarily in online fraud through gift cards and "burner phones," often used for illegal purposes. 

Surgepays Inc has several potential growth opportunities, including expanding its product and service offerings, acquiring smaller competitors, and expanding into new markets. The company has recently launched a new ISO program, which has the potential to generate significant revenue growth. The company has also been actively seeking strategic acquisitions, focusing on companies that can help expand its geographic reach and product offerings.

Surgepays Inc faces several potential risks and challenges, including increasing competition from larger retailers, regulatory and political pressures, and the potential for economic downturns. The company's focus on small retailers is also a potential weakness, as these retailers are more susceptible to economic downturns and other market pressures. Surgepays must continue to innovate and differentiate itself to maintain its competitive position.

SURG Stock Price History

SURG Stock News Headlines

“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Here's what to expect from SurgePays's earnings report
3 Rarely Talked About Stocks Ready to Make People Rich
See More Headlines
Receive SURG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SurgePays and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
7/26/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Telephone communication, except radio
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SURG
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.50
High Stock Price Target
$9.50
Low Stock Price Target
$9.50
Potential Upside/Downside
+213.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$20.62 million
Pretax Margin
11.56%

Debt

Sales & Book Value

Annual Sales
$137.14 million
Cash Flow
$1.26 per share
Book Value
$1.68 per share

Miscellaneous

Free Float
13,705,000
Market Cap
$58.81 million
Optionable
Optionable
Beta
1.00
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Kevin Brian Cox (Age 49)
    Chairman & CEO
    Comp: $1.65M
  • Mr. Anthony George Evers CPA (Age 60)
    CIA, CPA, CFO & Acting COO
    Comp: $1.03M
  • Mr. David C. Ansani J.D. (Age 59)
    M.B.A., Director of Legal/Human Resources Services, Secretary & Chief Administrative Officer
    Comp: $423.83k
  • Mr. Jeremy Gies (Age 49)
    President
  • Mr. John MottMr. John Mott
    Chief Technology Officer
  • Mr. Carter M. Matzinger (Age 49)
    Chief Strategic Officer of LogicsIQ
    Comp: $187.21k
  • Mr. Brian M. Prenoveau C.F.A.
    Managing Director of MZ

SURG Stock Analysis - Frequently Asked Questions

How have SURG shares performed this year?

SurgePays' stock was trading at $6.45 at the start of the year. Since then, SURG stock has decreased by 53.5% and is now trading at $3.00.
View the best growth stocks for 2024 here
.

How were SurgePays' earnings last quarter?

SurgePays, Inc. (NASDAQ:SURG) released its quarterly earnings data on Monday, May, 13th. The medical equipment provider reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.27 by $0.20. The medical equipment provider earned $31.43 million during the quarter, compared to analyst estimates of $32.40 million. SurgePays had a trailing twelve-month return on equity of 55.35% and a net margin of 12.93%.

How do I buy shares of SurgePays?

Shares of SURG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of SurgePays own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SurgePays investors own include Agilent Technologies (A), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Celldex Therapeutics (CLDX), Genocea Biosciences (GNCA), GTX (GTXI) and Idera Pharmaceuticals (IDRA).

This page (NASDAQ:SURG) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners